Lipella Pharmaceuticals Inc

-0.08 (-4.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Lipella Pharmaceuticals Inc Stock, NASDAQ:LIPO

7800 Susquehanna Street, Suite 505, Pittsburgh, Pennsylvania 15208
United States of America
Phone: +1.412.901.0315
Number of Employees: 7


Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.